Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases.

ABSTRACT:

SUBMITTER: Xie J 

PROVIDER: S-EPMC10437654 | biostudies-literature | 2011 Oct

REPOSITORIES: biostudies-literature